TEAS RF New Application

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88464386

Filing Date: 06/07/2019

To the Commissioner for Trademarks:

MARK: hb (stylized and/or with design, see mark)

The literal element of the mark consists of hb.
The applicant is not claiming color as a feature of the mark. The mark consists of the letters "hb" in lower case letters with the letter "h" at the top and the letter "b" on the bottom sharing the end of the letter "h" slant to form the "b".
The applicant, HEMISPHERX, a corporation of Delaware, having an address of
      860 N. Orange Avenue, Suite B
      Orlando, Florida 32801
      United States
      703-816-4003(phone)
      703-816-4100(fax)
      nixonptomail@nixonvan.com (not authorized)

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 005:  ntravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

       International Class 042:  Pharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS

In International Class 042, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 06/05/1995, and first used in commerce at least as early as 06/05/1995, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) copies of website pages showing use of mark for services.

Original PDF file:
SPE0-65207123177-20190607155402235126_._hb-Class_42_specimen.pdf
Converted PDF file(s) (3 pages)
Specimen File1
Specimen File2
Specimen File3



The applicant's current Attorney Information:
      Donna J. Bunton and Every attorney at law associated with NIXON & VANDERHYE P.C. of NIXON & VANDERHYE P.C.      901 North Glebe Road, 11th Floor
      Arlington, Virginia 22203
      United States
      703-816-4003(phone)
      703-816-4100(fax)
      nixonptomail@nixonvan.com (authorized)
The attorney docket/reference number is DJB/51-771.

The applicant's current Correspondence Information:

Donna J. Bunton

NIXON & VANDERHYE P.C.

901 North Glebe Road, 11th Floor

Arlington, Virginia 22203

703-816-4003(phone)

703-816-4100(fax)

nixonptomail@nixonvan.com;djb@nixonvan.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /Donna J. Bunton/   Date: 06/06/2019
Signatory's Name: Donna J. Bunton
Signatory's Position: Attorney for Applicant (VA Bar Member)
Payment Sale Number: 88464386
Payment Accounting Date: 06/10/2019

Serial Number: 88464386
Internet Transmission Date: Fri Jun 07 16:12:18 EDT 2019
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XXX-201906071612186
23527-88464386-620d8c33f49bdf21f76577ced
d9e9bf2b1973720b4873fcdd820225dc7b57faa-
CC-2890-20190607155402235126